Today, I’m doing something I thought I’d never do… Especially since I’m not normally a “swing for the fences” type of trader. But I’ve been quietly testing a new type of trade for a while now… And the returns are too good not to share with you. Take a look… I can’t guarantee results or against losses, but if you want to discover how I’ll target the triple return before the end of the week

watch this FREE briefing with me and expert trader Graham Lindman

OPK Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 47.26%

Insider Buying (Last 12 Months): $9,558,899.89

Insider Selling (Last 12 Months): $23,874,134.15

OPKO Health Insider Trading History Chart

OPKO Health Share Price & Price History

^$1.62

▲ +0.04 (2.53%)

As of 11/25/2024 01:00 AM ET

Days: 30 | 90 | 365

Ever heard of this 8-day bitcoin profit window?

From ProsperityPub | Ad

Did you know Bitcoin almost always soars higher during an 8-Day Profit Window? Most people have no clue… But for over a year now, some of our top students have had the chance to cash in with some incredible gains during this 8-day window.

It’s coming up quick.

OPKO Health Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
11/22/2024	Phillip Frost	CEO	Buy	100,000	$1.59	$159,000.00	211,712,405
11/14/2024	Phillip Frost	CEO	Buy	100,000	$1.62	$162,000.00	211,612,405
11/8/2024	Phillip Frost	CEO	Buy	280,183	$1.50	$420,274.50	211,512,405
8/19/2024	Opko Health, Inc.	Major Shareholder	Sell	50,000	$34.49	$1,724,500.00	2,646,972
8/15/2024	Opko Health, Inc.	Major Shareholder	Sell	39,824	$33.08	$1,317,377.92	2,746,972
8/12/2024	Opko Health, Inc.	Major Shareholder	Sell	59,787	$33.95	$2,029,768.65	2,811,783
8/8/2024	Opko Health, Inc.	Major Shareholder	Sell	100,000	$31.82	$3,182,000.00	2,871,570
8/6/2024	Opko Health, Inc.	Major Shareholder	Sell	12,994	$29.35	$381,373.90	2,971,570
7/31/2024	Opko Health, Inc.	Major Shareholder	Sell	88,839	$33.50	$2,976,106.50	2,984,564
7/29/2024	Opko Health, Inc.	Major Shareholder	Sell	50,000	$33.86	$1,693,000.00	3,073,403
7/26/2024	Opko Health, Inc.	Major Shareholder	Sell	60,000	$33.85	$2,031,000.00	3,123,403
7/24/2024	Opko Health, Inc.	Major Shareholder	Sell	75,000	$33.72	$2,529,000.00	3,183,403
7/22/2024	Opko Health, Inc.	Major Shareholder	Sell	50,000	$32.61	$1,630,500.00	3,333,403
7/19/2024	Opko Health, Inc.	Major Shareholder	Sell	25,000	$32.29	$807,250.00	3,383,403
7/17/2024	Opko Health, Inc.	Major Shareholder	Sell	25,000	$32.93	$823,250.00	3,408,403
7/5/2024	Opko Health, Inc.	Major Shareholder	Sell	36,118	$28.24	$1,019,972.32	3,433,403
7/3/2024	Opko Health, Inc.	Major Shareholder	Sell	14,082	$28.23	$397,534.86	3,469,521
7/1/2024	Opko Health, Inc.	Major Shareholder	Sell	50,000	$26.63	$1,331,500.00	3,508,603
5/23/2024	Phillip Frost	CEO	Buy	100,000	$1.27	$127,000.00	211,232,222
5/17/2024	Phillip Frost	CEO	Buy	163,997	$1.29	$211,556.13	211,132,222
3/18/2024	Phillip Frost	CEO	Buy	500,000	$0.87	$435,000.00	210,968,225
3/14/2024	Phillip Frost	CEO	Buy	500,000	$0.89	$445,000.00	210,468,225
3/12/2024	Phillip Frost	CEO	Buy	600,000	$0.93	$558,000.00	209,468,225
2/28/2024	Phillip Frost	CEO	Buy	500,000	$0.99	$495,000.00	208,868,225
2/21/2024	Phillip Frost	CEO	Buy	1,000,000	$0.99	$990,000.00	208,368,225
2/7/2024	Phillip Frost	CEO	Buy	1,500,000	$0.98	$1,470,000.00	207,368,225
1/29/2024	Richard M Krasno	Director	Buy	30,000	$0.99	$29,700.00	103,333
1/18/2024	Phillip Frost	CEO	Buy	400,000	$0.97	$388,000.00	205,368,225
1/17/2024	Jane Ph D Hsiao	Vice Chairman	Buy	150,000	$0.95	$142,500.00	27,999,880
1/16/2024	Phillip Frost	CEO	Buy	1,000,000	$0.95	$950,000.00	204,968,225
1/11/2024	Phillip Frost	CEO	Buy	511,531	$0.94	$480,839.14	203,968,225
1/8/2024	Gary J Nabel	Insider	Buy	216,184	$0.93	$201,051.12	351,442
1/5/2024	Elias A Zerhouni	Vice Chairman	Buy	550,300	$0.93	$511,779.00	20,327,814
1/5/2024	Phillip Frost	CEO	Buy	1,500,000	$0.90	$1,350,000.00	203,456,694
1/5/2024	Richard C Pfenniger Jr	Director	Buy	25,000	$0.94	$23,500.00	325,000
1/5/2024	Steven D Rubin	VP	Buy	10,000	$0.87	$8,700.00	6,187,732
11/13/2023	Richard C Pfenniger Jr	Director	Buy	25,000	$1.30	$32,500.00	300,000
11/10/2023	Jane Ph D Hsiao	Vice Chairman	Buy	100,000	$1.27	$127,000.00	27,699,870
11/10/2023	Steven D Rubin	VP	Buy	10,000	$1.30	$13,000.00	6,177,732
11/9/2023	Phillip Frost	CEO	Buy	500,000	$1.28	$640,000.00	201,456,694
8/17/2023	Phillip Frost	CEO	Buy	100,000	$1.76	$176,000.00	200,956,694
8/14/2023	Phillip Frost	CEO	Buy	75,000	$1.75	$131,250.00	200,856,694
8/14/2023	Phillip Frost	CEO	Buy	75,000	$1.75	$131,250.00	200,856,694
8/9/2023	Phillip Frost	CEO	Buy	100,000	$1.82	$182,000.00	200,781,694
8/7/2023	Phillip Frost	CEO	Buy	650,000	$1.84	$1,196,000.00	200,681,694
5/5/2023	Gary J Nabel	Insider	Buy	187,608	$1.81	$339,570.48	263,079
3/22/2023	Phillip Frost	CEO	Buy	200,000	$1.32	$264,000.00	200,031,694
3/8/2023	Phillip Frost	CEO	Buy	1,000,000	$1.18	$1,180,000.00	199,831,694
1/26/2023	Opko Health, Inc.	Major Shareholder	Buy	14,285,714	$0.35	$4,999,999.90	94,285,714
11/22/2022	Phillip Frost	CEO	Buy	300,000	$1.49	$447,000.00	198,831,694
11/9/2022	Phillip Frost	CEO	Buy	200,000	$1.60	$320,000.00	198,531,694
10/27/2022	Phillip Frost	CEO	Buy	100,000	$1.82	$182,000.00	198,331,694
10/19/2022	Phillip Frost	CEO	Buy	100,000	$1.72	$172,000.00	198,231,694
10/14/2022	Phillip Frost	CEO	Buy	100,000	$1.72	$172,000.00	198,131,694
10/12/2022	Phillip Frost	CEO	Buy	100,000	$1.73	$173,000.00	197,931,694
10/7/2022	Phillip Frost	CEO	Buy	75,000	$1.77	$132,750.00	197,831,694
9/26/2022	Phillip Frost	CEO	Buy	50,000	$1.80	$90,000.00	197,756,694
9/23/2022	Phillip Frost	CEO	Buy	50,000	$1.85	$92,500.00	197,706,694
9/21/2022	Phillip Frost	CEO	Buy	50,000	$1.91	$95,500.00	197,606,694
9/19/2022	Phillip Frost	CEO	Buy	50,000	$1.97	$98,500.00	197,506,694
9/15/2022	Phillip Frost	CEO	Buy	200,000	$2.06	$412,000.00	197,456,694
8/17/2022	Phillip Frost	CEO	Buy	200,000	$2.54	$508,000.00	197,156,694
8/5/2022	Phillip Frost	CEO	Buy	350,000	$2.29	$801,500.00	196,956,694
6/22/2022	Gary J Nabel	Insider	Buy	240,000	$2.49	$597,600.00	19,857,514
6/21/2022	Phillip Frost	CEO	Buy	200,000	$2.39	$478,000.00	196,606,694
6/16/2022	Phillip Frost	CEO	Buy	100,000	$2.31	$231,000.00	196,406,694
6/13/2022	Phillip Frost	CEO	Buy	100,000	$2.36	$236,000.00	196,306,694
6/6/2022	Phillip Frost	CEO	Buy	100,000	$2.79	$279,000.00	196,206,694
5/31/2022	Phillip Frost	CEO	Buy	50,000	$3.02	$151,000.00	196,056,694
5/25/2022	Phillip Frost	CEO	Buy	50,000	$2.98	$149,000.00	196,006,694
5/18/2022	Phillip Frost	CEO	Buy	50,000	$2.88	$144,000.00	195,956,694
5/16/2022	Phillip Frost	CEO	Buy	150,000	$2.98	$447,000.00	195,906,694
5/13/2022	Phillip Frost	CEO	Buy	200,000	$3.00	$600,000.00	195,756,694
5/10/2022	Elias A Zerhouni	Vice Chairman	Buy	89,600	$2.79	$249,984.00	89,600
5/10/2022	Phillip Frost	CEO	Buy	400,000	$2.78	$1,112,000.00	195,156,694
3/14/2022	Phillip Frost	CEO	Buy	35,000	$3.04	$106,400.00
3/11/2022	Phillip Frost	CEO	Buy	100,000	$3.13	$313,000.00
2/28/2022	Phillip Frost	CEO	Buy	100,000	$3.11	$311,000.00
2/25/2022	Phillip Frost	CEO	Buy	750,000	$3.09	$2,317,500.00
2/14/2022	Phillip Frost	CEO	Buy	100,000	$3.04	$304,000.00
2/1/2022	Phillip Frost	CEO	Buy	150,000	$3.03	$454,500.00
1/26/2022	Phillip Frost	CEO	Buy	350,000	$2.98	$1,043,000.00

Tim Sykes’ Urgent Trade Alert: “Make this move now”

From Timothy Sykes | Ad

WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT about Trump or Biden dropping out of the race…

Click here to see a unique election-year trade

SEC Filings (Institutional Ownership Changes) for OPKO Health (NASDAQ:OPK)

64.63% of OPKO Health stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

OPKO Health Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/25/2024	World Investment Advisors LLC	40,717	$61K	0.0%	N/A	0.006%
11/20/2024	Virtu Financial LLC	80,660	$0.12M	0.0%	N/A	0.012%
11/19/2024	Barclays PLC	543,336	$0.81M	0.0%	+154.5%	0.080%
11/16/2024	Geode Capital Management LLC	8,374,745	$12.48M	0.0%	-5.1%	1.227%
11/15/2024	Barclays PLC	543,336	$0.81M	0.0%	+154.5%	0.080%
11/15/2024	Orion Portfolio Solutions LLC	30,000	$45K	0.0%	N/A	0.004%
11/15/2024	XTX Topco Ltd	108,652	$0.16M	0.0%	+166.5%	0.016%
11/15/2024	Whitefort Capital Management LP	134,490	$0.20M	0.1%	-66.6%	0.020%
11/15/2024	State Street Corp	8,715,510	$12.99M	0.0%	-8.7%	1.277%
11/15/2024	Point72 DIFC Ltd	47,972	$71K	0.0%	N/A	0.007%
11/15/2024	Centiva Capital LP	35,838	$53K	0.0%	-65.0%	0.005%
11/15/2024	Clearline Capital LP	726,582	$1.08M	0.0%	N/A	0.106%
11/15/2024	Point72 Asia Singapore Pte. Ltd.	92,699	$0.14M	0.0%	N/A	0.014%
11/14/2024	Verition Fund Management LLC	134,700	$0.20M	0.0%	N/A	0.020%
11/14/2024	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	605,058	$0.90M	0.0%	-19.8%	0.089%
11/14/2024	MetLife Investment Management LLC	143,576	$0.21M	0.0%	-23.3%	0.021%
11/13/2024	Rubric Capital Management LP	48,706,640	$72.57M	1.2%	+9.6%	7.137%
11/13/2024	BNP Paribas Financial Markets	246,967	$0.37M	0.0%	+736.7%	0.036%
11/13/2024	FMR LLC	21,795	$32K	0.0%	+103.6%	0.003%
11/12/2024	Charles Schwab Investment Management Inc.	4,212,355	$6.28M	0.0%	-16.6%	0.604%
11/12/2024	Integrated Investment Consultants LLC	156,173	$0.23M	0.0%	N/A	0.022%
11/9/2024	Intech Investment Management LLC	127,476	$0.19M	0.0%	N/A	0.018%
10/31/2024	Principal Financial Group Inc.	22,740	$34K	0.0%	-28.8%	0.003%
10/29/2024	Ground Swell Capital LLC	42,339	$63K	0.1%	N/A	0.006%
10/25/2024	Highline Wealth Partners LLC	116,680	$0.17M	0.1%	N/A	0.017%
10/24/2024	PFG Investments LLC	1,061,090	$1.58M	0.1%	+10.4%	0.152%
10/23/2024	Assenagon Asset Management S.A.	1,490,992	$2.23M	0.0%	+142.5%	0.214%
10/23/2024	Hennion & Walsh Asset Management Inc.	423,392	$0.63M	0.0%	-9.5%	0.061%
10/22/2024	Private Advisor Group LLC	35,301	$53K	0.0%	+242.7%	0.005%
10/10/2024	Exchange Traded Concepts LLC	387,108	$0.58M	0.0%	+135.7%	0.056%
10/3/2024	SG Americas Securities LLC	135,856	$0.20M	0.0%	+1,086.9%	0.019%
8/16/2024	Algert Global LLC	35,157	$44K	0.0%	N/A	0.005%
8/16/2024	Cim Investment Management Inc.	27,331	$34K	0.0%	-19.2%	0.004%
8/15/2024	The Manufacturers Life Insurance Company	138,016	$0.17M	0.0%	-16.1%	0.020%
8/15/2024	AQR Capital Management LLC	79,839	$100K	0.0%	-19.7%	0.011%
8/14/2024	Squarepoint Ops LLC	473,216	$0.59M	0.0%	N/A	0.068%
8/14/2024	ProShare Advisors LLC	54,027	$68K	0.0%	-25.4%	0.008%
8/13/2024	Rubric Capital Management LP	44,422,304	$55.53M	1.5%	+800.0%	6.373%
8/13/2024	Hollencrest Capital Management	90,000	$0.11M	0.0%	+14.0%	0.013%
8/12/2024	XTX Topco Ltd	40,769	$51K	0.0%	-27.4%	0.006%
8/12/2024	Hsbc Holdings PLC	45,573	$57K	0.0%	-38.5%	0.007%
8/9/2024	Renaissance Technologies LLC	284,743	$0.36M	0.0%	-79.3%	0.041%
8/9/2024	Dimensional Fund Advisors LP	2,654,535	$3.32M	0.0%	-9.1%	0.381%
8/8/2024	Y.D. More Investments Ltd	1,469,143	$1.84M	0.2%	N/A	0.211%
8/8/2024	American Century Companies Inc.	89,728	$0.11M	0.0%	N/A	0.013%
8/7/2024	PFG Investments LLC	960,965	$1.20M	0.1%	+2.5%	0.138%
8/5/2024	Arizona State Retirement System	97,563	$0.12M	0.0%	-16.5%	0.014%
8/1/2024	Rhumbline Advisers	602,095	$0.75M	0.0%	-9.8%	0.086%
8/1/2024	CIBC Asset Management Inc	20,322	$25K	0.0%	+79.1%	0.003%
7/31/2024	Van ECK Associates Corp	105,716	$0.13M	0.0%	-24.0%	0.015%
7/29/2024	Principal Financial Group Inc.	31,941	$40K	0.0%	-28.8%	0.005%
7/26/2024	Bank of New York Mellon Corp	1,392,766	$1.74M	0.0%	-5.1%	0.200%
7/20/2024	Hennion & Walsh Asset Management Inc.	467,855	$0.59M	0.0%	-39.7%	0.067%
7/18/2024	Assenagon Asset Management S.A.	614,720	$0.78M	0.0%	-51.0%	0.088%
5/20/2024	Virtu Financial LLC	21,863	$26K	0.0%	N/A	0.003%
5/17/2024	Comerica Bank	90,000	$0.11M	0.0%	+125.0%	0.013%
5/17/2024	Tidal Investments LLC	198,940	$0.24M	0.0%	N/A	0.029%
5/16/2024	California State Teachers Retirement System	422,677	$0.51M	0.0%	-5.0%	0.061%
5/16/2024	AWM Investment Company Inc.	1,300,000	$1.56M	0.2%	+18.2%	0.187%
5/15/2024	Price T Rowe Associates Inc. MD	445,981	$0.54M	0.0%	+4.1%	0.064%
5/15/2024	Lazard Asset Management LLC	215,439	$0.26M	0.0%	N/A	0.031%
5/15/2024	Teton Advisors Inc.	162,000	$0.19M	0.1%	-4.7%	0.023%
5/10/2024	Vanguard Group Inc.	29,501,231	$35.40M	0.0%	-25.8%	4.233%
5/8/2024	Headlands Technologies LLC	39,444	$47K	0.0%	N/A	0.006%
5/7/2024	SG Americas Securities LLC	32,137	$39K	0.0%	-86.8%	0.005%
5/1/2024	BNP Paribas Financial Markets	336,315	$0.40M	0.0%	+23.7%	0.048%
4/30/2024	Commonwealth Equity Services LLC	437,276	$0.53M	0.0%	+5.9%	0.063%
4/26/2024	SlateStone Wealth LLC	25,770	$31K	0.0%	N/A	0.004%
4/24/2024	Assenagon Asset Management S.A.	1,253,808	$1.50M	0.0%	+107.2%	0.180%
4/22/2024	PFG Investments LLC	937,265	$1.13M	0.1%	N/A	0.134%
4/17/2024	Hennion & Walsh Asset Management Inc.	776,020	$0.93M	0.0%	+11.4%	0.111%
4/4/2024	Moseley Investment Management Inc.	34,153	$41K	0.0%	N/A	0.005%
2/13/2024	Tower Research Capital LLC TRC	47,320	$71K	0.0%	+68.4%	0.006%
2/12/2024	IPG Investment Advisors LLC	20,000	$30K	0.0%	N/A	0.003%
2/9/2024	Aigen Investment Management LP	34,935	$53K	0.0%	-34.9%	0.005%
2/7/2024	BNP Paribas Financial Markets	271,872	$0.41M	0.0%	+349.8%	0.035%
2/7/2024	Teacher Retirement System of Texas	19,775	$30K	0.0%	-40.3%	0.003%
2/6/2024	Charles Schwab Investment Management Inc.	5,733,700	$8.66M	0.0%	+3.3%	0.742%
2/6/2024	Swiss National Bank	837,855	$1.27M	0.0%	-10.3%	0.108%
2/5/2024	Van ECK Associates Corp	132,935	$0.20M	0.0%	-11.8%	0.017%
2/5/2024	Choreo LLC	70,000	$0.11M	0.0%	N/A	0.009%
1/17/2024	Assenagon Asset Management S.A.	605,239	$0.96M	0.0%	-29.6%	0.078%
1/12/2024	SG Americas Securities LLC	244,294	$0.37M	0.0%	+19.3%	0.032%
1/10/2024	Northstar Group Inc.	27,785	$42K	0.0%	N/A	0.004%
12/19/2023	Public Employees Retirement System of Ohio	144,928	$0.23M	0.0%	+1,509.6%	0.019%
12/18/2023	Vanguard Group Inc.	39,322,773	$62.92M	0.0%	+0.0%	5.087%
11/24/2023	EP Wealth Advisors LLC	30,900	$49K	0.0%	+140.3%	0.004%
11/16/2023	Horizon Family Wealth Inc.	55,160	$84K	0.0%	N/A	0.007%
11/14/2023	Oracle Investment Management Inc.	450,564	$0.72M	0.2%	-89.9%	0.058%
11/13/2023	Connor Clark & Lunn Investment Management Ltd.	1,419,957	$2.27M	0.0%	+30.0%	0.184%
11/13/2023	River Wealth Advisors LLC	23,500	$38K	0.0%	N/A	0.003%
11/13/2023	Aigen Investment Management LP	53,664	$86K	0.0%	N/A	0.007%
11/13/2023	Invesco Ltd.	5,164,180	$8.26M	0.0%	+300.4%	0.668%
11/13/2023	Kestra Advisory Services LLC	49,282	$79K	0.0%	N/A	0.006%
11/9/2023	Citigroup Inc.	1,483,758	$2.37M	0.0%	-8.2%	0.192%
11/8/2023	Van ECK Associates Corp	150,771	$0.24M	0.0%	+6.8%	0.020%
11/8/2023	Horizon Family Wealth Inc.	55,160	$84K	0.1%	N/A	0.007%
11/8/2023	Charles Schwab Investment Management Inc.	5,549,946	$8.88M	0.0%	+7.9%	0.718%
11/8/2023	Teton Advisors Inc.	178,000	$0.29M	0.1%	-6.3%	0.023%
11/8/2023	Swiss National Bank	934,055	$1.49M	0.0%	+1.0%	0.121%

Data available starting January 2016

OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories that offers laboratory testing services for the detection, diagnosis, evaluation, monitoring, and treatment of diseases, including esoteric testing, molecular diagnostics, anatomical pathology, genetics, women's health, and correctional healthcare to physician offices, clinics, hospitals, employers, and governmental units; and 4Kscore prostate cancer test. Its Pharmaceutical segment offers Rayaldee to treat secondary hyperparathyroidism in adults with stage 3 or 4 chronic kidney disease, and vitamin D insufficiency. This segment also develops multi-specific immune therapies focused on oncology, infectious diseases, vaccines, and immunology; OPK88004, an orally administered selective androgen receptor modulator; OPK88003, a once-weekly administered peptide for the treatment of type 2 diabetes and related obesity; Somatrogon (hGH-CTP), a once-weekly human growth hormone injection; and Factor VIIa-CTP, a novel long-acting coagulation factor being developed to treat hemophilia. In addition, it develops and commercializes longer-acting proprietary versions of already approved therapeutic proteins; develops and produces specialty APIs; develops, manufactures, markets, and sells pharmaceutical, nutraceutical, veterinary, and ophthalmic products; commercializes food supplements and over the counter products; manufactures and sells products primarily in the generics market; and markets, distributes, and sells pharmaceutical products in a range of indications, including cardiovascular products, vaccines, antibiotics, gastro-intestinal products, hormones, and others. The company also operates pharmaceutical platforms in Ireland, Chile, Spain, and Mexico. The company was founded in 1991 and is headquartered in Miami, Florida.

Today's Range

Now: $1.62

$1.59

$1.65

50 Day Range

MA: $1.52

$1.40

$1.66

52 Week Range

Now: $1.62

$0.85

$1.75

Volume

4,131,874 shs

Average Volume

6,913,393 shs

Market Capitalization

$1.11 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.65

Who are the company insiders with the largest holdings of OPKO Health?: OPKO Health's top insider investors include:
Phillip Md Et Al Frost (CEO)
Opko Health, Inc (Major Shareholder)
Jane Ph D Hsiao (Vice Chairman)
Elias A Zerhouni (Vice Chairman)
Steven D Rubin (VP)
Gary J Nabel (Insider)
Richard C Pfenniger Jr (Director)
Richard M Krasno (Director)
Learn More about top insider investors at OPKO Health.
Who are the major institutional investors of OPKO Health?: OPKO Health's top institutional investors include:
Rubric Capital Management LP — 7.14%
State Street Corp — 1.28%
Geode Capital Management LLC — 1.23%
Wolverine Asset Management LLC — 0.00%
Charles Schwab Investment Management Inc. — 0.60%
Assenagon Asset Management S.A. — 0.21%
Learn More about top institutional investors of OPKO Health stock.
Which institutional investors are selling OPKO Health stock?: Within the previous quarter, OPK stock was sold by these institutional investors:
Charles Schwab Investment Management Inc.
State Street Corp
Geode Capital Management LLC
Whitefort Capital Management LP
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Centiva Capital LP
Hennion & Walsh Asset Management Inc.
MetLife Investment Management LLC
Which institutional investors are buying OPKO Health stock?: Within the previous quarter, OPK stock was purchased by institutional investors including:
Rubric Capital Management LP
Assenagon Asset Management S.A.
Clearline Capital LP
Barclays PLC
Barclays PLC
Exchange Traded Concepts LLC
BNP Paribas Financial Markets
Integrated Investment Consultants LLC
During the last year, these company insiders have bought OPKO Health stock:
Phillip Md Et Al Frost (CEO)
Opko Health, Inc (Major Shareholder)
Jane Ph D Hsiao (Vice Chairman)
Elias A Zerhouni (Vice Chairman)
Steven D Rubin (VP)
Gary J Nabel (Insider)
Richard C Pfenniger Jr (Director)
Richard M Krasno (Director)
Learn More investors buying OPKO Health stock.

I've got news for you…

From DTI | Ad